1. Market Research
  2. > Manufacturing Market Trends
  3. > 3D Printing for Healthcare, Trends, R&D and Revenue Forecasts 2016-2026: Explore Dental Products, Medical Implants, Pharmaceuticals, Bio-printing and Other Uses for Additive Manufacturing

Report Details
Three dimensional printing for medicine – your new guide to trends, opportunities and sales potentials
What is the future of fabricating objects from digital models with 3D printers? Visiongain’s new report gives you that data and analysis, letting you explore developments, technology and revenue predictions for uses in healthcare industries.

Our investigation forecasts those revenues to 2026 at overall world market, submarket and national level. Avoid falling behind in knowledge, missing opportunities or losing influence. Instead see what the future holds for additive manufacturing and find the potential gains.

Advances in 3D printing for medicine – find where that printer technology heads
With our updated study you explore the commercial prospects of those computer controlled industrial robots. See outlooks for medical devices, tissues, drugs and other applications.

That way you find potentials for those production tools for creating shapes and patterns as multiform designs. See how those advances can benefit medicine.

Those technologies hold crucial opportunities. So read on to explore that industry and see what its future market could be worth.

Forecasts to 2026 and other information to help you stay ahead in knowledge
Besides revenue forecasting to 2026, our new work shows you recent results, sales growth rates and market shares. You also explore R&D and leading companies. Our study gives 56 tables, 58 charts and seven interviews with other authorities.

Information to help your work and save time, benefiting your influence
Is finding data on novel prototyping and production systems for healthcare proving a challenge? Now make your work easier, also saving time. Discover what the future holds for that emerging technology you cannot afford to ignore.

That way you help yourself stay ahead in knowledge, benefiting your analyses, decisions, authority and reputation for insight.

Forecasting of that world market and its main segments – what is likely to happen?
What are the secrets of 3D printing’s progress? What is the potential of that chemistry, engineering and biotechnology for healthcare? Discover in our report overall world revenue to 2026 for those synthetic processes for medical applications.

Also find individual revenue predictions to 2026 for six submarkets at world level:
- Products – with sub-forecasts for dental products, medical implants, bio-printed tissue and other applications
- Technology – processes for supporting those developments.

Which operations and processes will generate most money from 2016? With our investigation you assess outlooks for revenue growth, seeing where you can gain.

Our analysis helps you identify potential in that synthesis for medicine, producing complex geometries and surfaces. Explore the best revenue-generating applications.

Also see how that emerging industry gives opportunities from 2016 in developed and developing countries.

National markets – where will highest revenues and fastest business expansion occur?
Needs for medical devices, diagnostics and pharmaceuticals worldwide expand use of manufacturing technologies using 3D print methods. In our investigation you examine the scope of three-dimensional printing.

Our analysis shows you individual revenue forecasts to 2026 for 11 countries:
- United States (US)
- Japan
- Germany, France, UK, Italy and Spain (EU5 countries)
- Brazil, Russia, India and China (BRIC group).

In our work you find regions with highest revenues, demand and sales potentials for that production. You discover international prospects, appraising needs and demands.

So explore how technology for multidimensional printing can benefit its developers, producers, marketers, sellers and users from 2016. Our work shows you, discussing trends, prospects and issues.

Events and forces for developing, producing, marketing and selling
The report explains forces affecting that industry and market, including these trends:
- Technologies including selective laser sintering (SLS), direct metal laser sintering (DMLS), electron beam melting (EBM), stereolithography (SLA) and selective laser melting (SLM)
- Bio-printed tissues, cells and compounds, including pharmaceuticals
- Medical models, surgical guides and prototypes
- Orthopaedic and cranio-maxillofacial implants and other medical devices.

You also see how these issues affect that industry and its users:
- Regulatory requirements – abridged pathways, innovations and challenges with 3D technologies and materials
- Replicating vascular tissue – a challenge restraining the bio-printing of replacement organs
- Intervertebral discs, bioengineering, skin grafts, implantable cartilage, blood vessels, heart, lung, liver, bone and reconstructive surgery
- Other advances in research and development, including improving biocompatibility and enhancing usefulness of the 3-dimensional constructs.

In our study you explore economic, political, social and technological questions, investigating outlooks for business. Examine what stimulates and restrains that industry and market. You hear what success is possible and see how you can gain.

Companies and overall 2020 market value – how high can 3D shaping revenues go?
What does the future hold? Our report predicts the world market for those multidimensional printer technologies for health will generate $2854 million in 2020, with further multiplication of revenue to 2026. Discover what is possible.

From 2016, healthcare corporations and specialty providers of that chemical and engineering technology can prosper. You discover how, why and when progress can occur. See what is possible.

You assess activities, progress and outlooks of organisations including these:
- Stratasys
- 3D Systems
- EOS
- Tissue Regeneration Systems
- Oxford Performance Materials
- Tronrud Engineering
- Arcam AB
- Organovo
- Bio3D Technologies
- Aprecia Pharmaceuticals Company.

In our study you also discover seven interviews with authorities in the field – technology firms and other organisations. That way you find what companies and other innovators say, think and do, helping you stay ahead in knowledge.

6 Ways 3D Printing for Healthcare, Trends, R&D and Revenue Forecasts 2016-2026 helps you
In these six main ways, our new study benefits your research, plans, decisions and presentations:
- Revenues to 2026 at world level and for 6 submarkets – see outlooks for that emerging industry, its technology, marketing and sales
- Forecasts to 2026 for 11 national markets in the Americas, Europe and Asia – investigate leading countries for potential revenues and expansion
- Prospects for companies and other organisations – assess portfolios, progress, advantages, business strategies and developmental activities
- Discussions of R&D – explore progress in that industry, finding technological, clinical and commercial opportunities and outlooks
- Analysis of what stimulates and restrains that market – assess challenges and strengths, helping you compete and gain advantages
- Interviews with 7 authorities in that field – researchers and companies – discover news and views to help you stay ahead and succeed.

That analysis, by our in-house team in the UK, gives knowledge to benefit your research, plans, decisions and proposals. It shows data you find nowhere else.

Knowledge found only in our work, helping your research, analyses and plans
Our report gives independent analysis. There you receive business intelligence found only in our work, finding where progress and money lie. With that knowledge you explore possibilities, helping you stay ahead and succeed.

With our updated and expanded investigation you are less likely to fall behind in information or miss opportunity. Find out how you could save time and effort. Also benefit your decisions and authority on that emerging, rising technology.

Trying our analysis now lets you explore 3D printing opportunities and predictions
Our new study is for everyone investigating 3D production techniques, equipment and devices for healthcare. In it you find revenue forecasting to 2026, with trends, analysis, data and discussions. Avoid missing out – please get our report here now.

Table Of Contents

3D Printing for Healthcare, Trends, RandD and Revenue Forecasts 2016-2026: Explore Dental Products, Medical Implants, Pharmaceuticals, Bio-printing and Other Uses for Additive Manufacturing
1. Report Overview
1.1 Overview of 3D Printing for Healthcare: RandD, Industry and Market 2016-2026
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2. Introduction to the 3D Printing for the Healthcare Industry
2.1 3D Printing
2.1.1 Stereolithography - The First 3D Printing Method
2.1.2 Selective Laser Sintering (SLS), Direct Metal Laser Sintering (DMLS) and Selective Laser Melting (SLM)
2.1.3 Electron Beam Melting (EBM)
2.2 Bio-printing Organic Living Cells
2.2.1 Approaches to Bio-printing
2.2.2 Applications for Bio-printing
2.3 3D Printing Pharmaceuticals
2.4 Classifying Medical Devices
2.4.1 The US Medical Devices Classification System
2.4.2 The EU Medical Device Classification System

3. The 3D Printing Healthcare Global Market 2016-2026
3.1 The Current State of the 3D Printing for Healthcare Market
3.2 3D Printed Products in the Healthcare Industry: Submarket Breakdown
3.2.1 Dental Product Submarket is still the Current Majority Market Share Holder
3.3 Global Forecast for the 3D Printed Market 2016-2026
3.4 Drivers and Restraints for the Global 3D Printed Healthcare Market
3.4.1 Drivers of the Global 3D Printed Healthcare Market
3.4.2 Restraints for the 3D Printed Healthcare Market
3.5 The 3D Printing Market for Healthcare: Technology vs. Products Revenue Forecast
3.5.1 Technology: Revenue Forecast 2016-2026
3.5.2 Drivers and Restraints for the 3D Printed Healthcare Technology Submarket
3.5.3 Products Revenue Forecast 2016-2026
3.5.4 Drivers and Restraints for the 3D Printed Healthcare Products Submarket
3.6 The 3D Printing Market for Healthcare: Product Submarket Revenue Forecasts 2016-2026
3.6.1 Dental Products: Revenue Forecast 2016-2026
3.6.2 Medical Implants: Revenue Forecast 2016-2026
3.6.2.1 Medical Implants: Patient-Specific Orthopaedic and Cranio-maxillofacial Implants Are Produced Using 3D Printing Technology
3.6.2.2 Drivers and Restraints for the 3D Printed Medical Implants, 2016
3.6.2.3 FDA Approvals for 3D Printed Medical Implants
3.6.3 Bio-printed Tissue: Revenue Forecast 2016-2026
3.6.4 Bio-printed Tissue: Commercial Uses
3.6.4.1 Bio-printed Liver Tissue: Preclinical Drug Testing
3.6.4.2 Bio-printed Skin: Opportunities in Cosmetics and Burn Victims
3.6.4.3 Bio-printed Cartilage: Facial Disfigurements and Knee Replacements
3.6.5 Other Applications: Revenue Forecast 2016-2026
3.6.5.1 3D Printed Surgical Tools: Accurate yet Expensive
3.6.5.2 3D Printed Medical Modelling
3.6.5.3 3D Printed Pharmaceuticals: 2015 Sees the First FDA Approval
3.6.5.4 3D Printing to Help Combat Cancer

4. Leading National Markets for 3D Printing in Healthcare 2016-2026
4.1 Leading National Markets for 3D Printing in Healthcare, 2016
4.2 Leading National Markets for 3D Printing in Healthcare, 2020
4.3 Leading National Markets for 3D Printing in Healthcare, 2026
4.4 The US will be the Dominant Market in 3D Printed Healthcare for the Duration of the Forecast
4.4.1 America Makes: A ‘National Accelerator' for US 3D Printed Products
4.4.2 FDA Regulatory Requirements: Abridged Pathways Encourage Innovation
4.5 The EU5 Will Account for almost third of the Market in 2016; How Will This Change over the Coming 10 years?
4.5.1 Germany Will Remain the Largest Market of the EU5 Throughout the Forecast Period
4.5.2 France Demonstrates Strong Growth but a Deceasing Market Share
4.5.3 The UK: A Strong Network for 3D Printed Medical Implants Will Stimulate Sales of those Products
4.5.4 Italian Orthopaedic Manufacturers are Prominent Consumers of AM Technology
4.5.5 Spain has the Smallest 3D Printing for Healthcare Market in the EU5
4.6 Japan Will be Overtaken as the Second Largest Market by China in 2017
4.7 The BRIC Nations Show Strong Growth from 2020-2026
4.7.1 China: Domestic Innovation is Keeping Pace with the West
4.7.1.1 Chinese Market Restraints to 3D Printing for Healthcare
4.8 Russian Recession Creates Challenges from 2015-2019
4.9 Brazil's Rapidly Growing Dental Market Presents Opportunities for 3D Printing
4.10 The Indian Market is in its Infancy
4.11 The Rest of The World Market is Fast Growing

5. Market Leading Organisations
5.1 Market Leaders in Technology: Hardware and Software
5.1.1 Stratasys: Activities and Outlooks
5.1.1.1 Growth Strategies for Stratasys
5.1.2 3D Systems: Achievements and Activities
5.1.3 EOS: A Market Leader in the Technology Submarket
5.1.4 Autodesk Within: Autodesk Acquires Within Technologies
5.1.5 Renishaw: UK-based 3D Printer Manufacturer
5.2 Market Leaders in the Medical Implant/Dental Product Submarkets
5.2.1 Tissue Regeneration Systems: Commercialising 3D Printed Bioresorbable Skeletal Reconstruction Implants
5.2.2 Oxford Performance Materials: Innovators with FDA Approvals to Match
5.2.3 CandA Tool: Manufacturing Parts for the Surgical, Orthopaedic, Implant and Tooling Fields
5.2.4 Tronrud Engineering: A Provider
5.2.5 Aortica: Abdominal Aortic Aneurysm Specialists
5.2.6 Proto Labs Acquires Alphaform AG
5.2.7 3T RPD Ltd: A Large Contributor to the U.K. National Market
5.2.8 Arcam AB: Acquisitions Give Coverage of the Entire Production Line
5.2.9 Xilloc Medical: Patient-Specific Implants from Design to Production.
5.2.10 Fripp Design and Research: Commercial Products in the Pipeline
5.2.11 Materialise NV: A Global Software and Printing Services Provider
5.2.12 4WEB Medical: Strong Growth with More in the Pipeline
5.2.13 Replica 3dm: Offering Medical Models for the NHS
5.2.14 Zdravprint: 3D Printed Casts
5.3 Leading Organisations in the 3D Bio-printing Submarket
5.3.1 Organovo: the First Bio-printed Tissue on the Market
5.3.1.1 Organovo exVive 3D Bio-printed Liver Tissue
5.3.1.2 Organovo: 3D Printed Kidney Tissue in the Pipeline
5.3.2 RegenHU: Creating 3D Bio-printers and Bioinks
5.3.3 Bio 3D Technologies: The World's First Modular Bio-printer
5.3.4 Osteopore International: Two FDA Approved Products
5.3.5 EnvisionTEC: 3D Printing and Bio-printing Solutions
5.3.6 Dentca
5.3.7 Rainbow Biosciences: Bio-printing based on Magnetic Nanoparticles
5.3.8 Wake Forest Institute for Regenerative Medicine: 3D Bio-printing Research
5.3.8.1 Bio-printed Tissue for Drug Development
5.4 When will Bio-printing be Commercially Available?
5.5 3D Printed Pharmaceuticals: Was 2015 a Watershed Year for the Pharmaceutical Industry?
5.5.1 Aprecia Pharmaceuticals Receives FDA Approval for Spritam, the First of a Kind
5.5.2 The Cronin Group, University of Glasgow: Research into 3D Printing Pharmaceuticals
5.5.3 FabRx: Changing the Shape of Drugs

6. 3D Printing for the Healthcare Industry: The RandD Pipeline
6.1 The Pipeline for 3D Printed Medical Implants
6.1.1 3D Printed Tracheal Splints
6.1.2 Improving Biocompatibility of 3D Printed Medical Implants
6.1.2.1 Vitamin B2 Can Improve Biocompatibility of 3D Printed Medical Implants
6.1.2.2 Silicone is a Biocompatible Material Which Can be Used to Encase Implants
6.1.3 3D Printing for Spinal Implants
6.1.3.1 3D Printed Titanium Spinal Implants
6.1.3.2 3D Printed Intervertebral Discs Could Look Forward to a Share of a $90bn Market
6.1.3.3 3D Printing to Help Treat Babies With Spina Bifida
6.1.4 Printing a Bionic Eye
6.2 The Pipeline for 3D Printed Bioengineering
6.2.1 3D Printing Human Skin
6.2.2 3D Printing Cartilage: Research Making Commercial Availability Tangible
6.2.3 3D Printing Vascular Tissue is a Complex Challenge Restraining the Bio-printing of Entire Organs
6.2.3.1 Revotek: Creating a Blood Vessel Printer
6.2.3.2 Bio-ink Research at Harvard University
6.2.3.3 3D Printed Thryroid Gland - the First 3D Printed Organ?
6.2.3.4 Sugar and Silicone Casted Blood Vessels
6.2.3.5 The Artivasc 3D Project at the Fraunhofer Institute
6.2.4 3D Printing to Fabricate Artificial Heart Valves
6.2.5 3D Printing of the Nipple Areola Complex Graft for Reconstructive Surgery
6.2.6 3D Printing Stem Cells
6.3 The Pipeline for Other 3D Printed Healthcare Applications
6.3.1 Eyedrivomatic: A 3D Printed Wheelchair
6.3.2 3D Printed Pharmaceuticals: Changing Dose, Shape and API
6.3.2.1 3D Printed Polypill for Cardiovascular Disease
6.3.2.2 3D Printing New Active Pharmaceutical Ingredients
6.3.2.3 Aprecia Have Three Products in their Pipeline
6.3.2.4 Bringing Pharmaceuticals to Lesser Economically Developed Countries
6.3.3 3D Printed Microbots for Healthcare

7. Qualitative Analysis of the 3D Printing Industry for Healthcare, 2016-2026
7.1 Strengths of the 3D Printing for Healthcare Industry
7.1.1 Growth Rates Are High - 3D Printing Holds Great Potential
7.1.2 Demand for Customised Products is Increasing
7.1.3 3D Printed Products Can Improve Health Outcomes and Reduce Costs Incurred on Health Systems
7.1.4 More Efficient Use of Economic Resources in Manufacturing
7.1.5 3D Printing Produces Complex Shapes and Parts
7.1.6 3D Printing Technology is Advancing Rapidly
7.2 Weaknesses of the 3D Printing for Healthcare Industry
7.2.1 3D Printing is Expensive Technology
7.2.2 Traditional Economies of Scale Cannot Yet be Achieved with AM
7.2.3 AM is a New Technology which Requires Fewer Workers and New Expertise
7.2.4 Access to Technology and Expertise is Currently Limited
7.2.5 New Legislation will be Enforced Which Could Slow Advances
7.3 Opportunities for the 3D Printing for Healthcare Market, 2016-2026
7.3.1 Governments are Funding 3D Printing RandD Projects
7.3.2 Increasing Demand for Personalised Medicine Represents a Lucrative Opportunity
7.3.3 New Applications for 3D Printing Technology are Being Developed
7.3.4 Post-Production Finishing Will Require New Expertise
7.4 Threats to the 3D Printing for Healthcare Industry, 2016-2026
7.4.1 Regulatory Guidelines Must be Clarified
7.4.2 A Media Coverage May Lead to An Investment Bubble
7.4.3 High Volume Manufacturing is More Economical Using Traditional Methods
7.4.4 There May be Unknown Side Effects Harmful to Health
7.5 A STEP Analysis of the 3D Printing for Healthcare Market
7.6 Social Influences on the 3D Printing for Healthcare Market
7.7 Technological Influences on Market Trends
7.8 Economic Influences on the Market
7.9 Political Influences on the Market

8. Research Interviews
8.1 Interview with Dr Stephen Hilton, UCL School of Pharmacy, FabRx, 3D Synthesis
8.1.1 On 3D Printing Research at UCL, FabRx and 3D Synthesis
8.1.2 On the Use of Hardware and Software
8.1.3 On Commercial Ambitions for FAbRx
8.1.4 On the Benefits and Barriers to 3D Printing in Healthcare
8.2 Interview with Evan Youngstrom, Venture Counsel, Wilson Sonsini Goodrich and Rosati Professional Corporation
8.2.1 On Intellectual Property Challenges
8.2.2 On the Different Challenges Between Implants and Pharmaceuticals
8.2.3 On the First FDA Approved 3D Printed Drug
8.3 Interview with Peter Leys, Executive Chairman, Materialise N.V
8.3.1 On the Beginning of Materialise N.V.
8.3.2 On the Medical Products and Services Offered by Materialise N.V.
8.3.3 On Materialise's Most Lucrative Products and Markets in 2015 and Beyond
8.3.4 On Regulatory Challenges Facing 3D Printing in the Healthcare Industry
8.3.5 On the Prospects of Materialise N.V. Over the Forecast Period
8.4 Interview with Michael Renard, Executive Vice President, Commercial Operations, Organovo
8.4.1 On the Application for 3D Bio-printing
8.4.2 On the Commercial Prospects of the Technology
8.4.3 On the Potential Factors That Could Inhibit Development
8.4.4 On their Newly Released exVive 3D Liver Human Tissue
8.4.5 On the Future of Organovo and the 3D Bio-printing Industry
8.5 Interview with Jim Fitzsimmons, President and CEO, Tissue Regeneration Systems
8.5.1 On the Background of TRS
8.5.2 On TRS' Portfolio
8.5.3 On Their Commercialization Strategy
8.5.4 Future
8.6 Interview with Matthew Sherry, Managing Director, Replica 3dm
8.6.1 On the History Behind Replica 3dm
8.6.2 On Their Services and RandD Pipeline
8.6.3 On Replica 3DM's Growth Plans
8.6.4 On the 3D Printing for Healthcare Industry
8.7 Interview with Lee Cronin, Regius Chair of Chemistry, University of Glasgow
8.7.1 On the Cronin Group's 3D Printed Technology
8.7.2 On Commercialisation Opportunities for Their Technology

9. Conclusions from Our Study
9.1 The Overall 3D Printing for Healthcare Market can be Broken Down into Technology and Products
9.2 Revenue for 3D Printed Healthcare Product Submarkets 2016-2026
9.3 Leading National Markets for 3D Printing in the Healthcare Industry 2016-2026
9.4 Market Trends for 3D Printing in Healthcare 2016-2026
9.4.1 Centralised Organisations will Foster Growth
9.4.2 Opportunities in Technology Development and Raw Material Production
9.4.3 Increased Demand for Personalised Products is leading to Greater Penetration of Technology
9.4.4 3D Printing is Most Established in the Product Submarket of Dentistry
9.4.5 2015 Was a Landmark Year for the 3D Printed Pharmaceuticals
9.4.6 Bio-printing Will Start to Bring in Commercial Revenue Within the Forecast Period
9.4.7 Concluding Remarks

List of Tables
Table 1.1 Leading National Market Forecasts ($m): AGRs (%), Market Shares (%) and CAGRs (%) for 3D Printing in Healthcare, 2015-2026
Table 2.1 The US Classification of Medical Devices
Table 2.2 The EU Classification of Medical Devices
Table 3.1 Breakdown of the Market by Technology and Products: Revenue ($m) and Market Share (%), 2015
Table 3.2 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%), 2015, 2020 and 2026
Table 3.3 3D Printing for Healthcare: Global Market Forecast ($m), 2016-2026
Table 3.4 3D Printing Technology and Products for Healthcare: Market Share (%) and Market Size ($m), 2020
Table 3.5 3D Printing Technology and Products for Healthcare: Market Share (%) and Market Size ($m), 2026
Table 3.6 3D Printing Technology for Healthcare: Revenue Forecasts ($m), 2016-2026
Table 3.7 3D Printing Products for Healthcare: Revenue Forecast ($m), 2016-2026
Table 3.8 3D Printed Products for Healthcare by Submarket: Revenue ($m) and Market Share (%) Forecasts, 2016-2026
Table 3.9 3D Printing for Healthcare Product Submarket Revenue ($m) and Market Shares (%), 2015
Table 3.10 3D Printing for Healthcare Product Submarket Revenue ($m) and Market Shares (%), 2020
Table 3.11 3D Printing for Healthcare Product Submarket Revenue ($m) and Market Shares (%), 2026
Table 3.12 3D Printed Dental Products: Revenue ($m) and Market Share (%) Forecast, 2016-2026
Table 3.13 3D Printed Medical Implants: Revenue ($m) and Market Share (%) Forecast, 2016-2026
Table 3.14 Bio-printed Tissue: Revenue ($m) and Market Share (%) Forecast, 2016-2026
Table 3.15 Other Applications: Revenue ($m) and Market Share (%) Forecast, 2016-2026
Table 4.1 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Comparisons of Revenue ($m) and Market Share (%), 2016, 2020, 2026
Table 4.2 Leading National Markets ($m) and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2020
Table 4.3 Leading National Markets ($m) and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2026
Table 4.4 Leading National Markets: Revenue Forecasts ($m), AGRs (%), Market Shares (%) and CAGRs (%) for 3D Printing in Healthcare, 2015-2026
Table 4.5 US 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2016-2026
Table 4.6 EU5 National Markets ($m) for 3D Printing for Healthcare Forecast, 2016-2026
Table 4.7 German National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.8 French National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.9 UK National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.10 Italian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.11 Spanish National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.12 Japanese National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.13 Chinese National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.14 Russian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.15 Brazilian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.16 Indian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.17 RoW National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 5.1 Market Leading Organisations in the 3D Printing for Healthcare Market, 2016
Table 5.2 Stratasys Acquisition History
Table 5.3 3D Systems Healthcare-Related Acquisition History, 2012-2014
Table 5.4 Medical Implants Designed Using Within Technologies' Software
Table 5.5 Renishaw Overall Revenue ($m) and Revenue from Healthcare ($m), 2011-2016
Table 5.6 Oxford Performance Materials' Products to Receive FDA 510(K) Clearance
Table 5.7 Raw Materials Supplied by EOS and Used by CandA Tools for 3D Printed Products
Table 5.8 Arcam AB Actual Net Sales and Net Sales of Implants (2010-2014) and Forecasted Net Sales and Net Sales of Implants (2015-16)
Table 5.9 Leading Organisations in 3D Bio-printing, 2016
Table 5.10 EnvisionTEC 3D Printing Systems Available for the Medical and Dental Industries, 2016
Table 5.11 Prominent Organisations in the 3D Printed Pharmaceutical Industry, 2016
Table 6.1 Pipeline Areas and Locations of Research for 3D Printed Medical Implants, 2016
Table 6.2 Pipeline Areas and Locations of Research for 3D Printed Bioengineered Products, 2016
Table 6.3 Wake Forest Institute for Regenerative Medicine Research Areas, 2016
Table 6.4 Pipeline Areas and Locations of Research for Other 3D Printed Healthcare Applications, 2016
Table 7.1 Strengths and Weaknesses of the 3D Printing Industry for Healthcare, 2016
Table 7.2 Opportunities and Threats for the 3D Printing Industry for Healthcare, 2016-2026
Table 7.3 Platinum Member of America Makes, 2016
Table 7.4 Public Partners of America Makes, 2016
Table 7.5 Technological Improvements on 3D Printing Systems, 2016
Table 7.6 Technological Improvements on 3D Printing Software, 2016
Table 7.7 Technological Improvements on 3D Printing Raw Materials, 2016

List of Figures
Figure 1.1 Breakdown of the 3D Printing for Healthcare Market, 2016
Figure 3.1 Breakdown of the Market by Manufacturing Technology and Products, 2015
Figure 3.2 3D Printed Products for Healthcare by Application Market Share (%), 2015
Figure 3.3 Global Revenue Forecast for the 3D printed Healthcare Market, 2016-2026
Figure 3.4 3D Printing in the Healthcare Industry: Annual Growth Rates, 2016-2026
Figure 3.5 Drivers and Restraints of the 3D Printing for Healthcare Industry, 2016
Figure 3.6 3D Printing Technology and Products for Healthcare: Market Share (%), 2020
Figure 3.7 3D Printing Technology and Products for Healthcare: Market Share (%), 2026
Figure 3.8 Technology Revenue Forecast for the 3D Printed Healthcare Market, 2016-2026
Figure 3.9 Drivers and Restraints for the 3D Printed Healthcare Technology Submarket, 2016
Figure 3.10 Product Revenue ($m) Forecast for the 3D printed Healthcare Market, 2016-2026
Figure 3.11 Product AGR (%) Forecast for the 3D printed Healthcare Market, 2016-2026
Figure 3.12 Drivers and Restraints for the 3D Printed Healthcare Product Submarkets, 2016
Figure 3.13 3D Printed Products for Healthcare by Application: Revenue Forecast ($m), 2016-2026
Figure 3.14 3D Printing for Healthcare Product Submarket Revenue Shares (%), 2015
Figure 3.15 3D Printing for Healthcare Product Submarket Revenue Shares (%), 2020
Figure 3.16 3D Printing for Healthcare Product Submarket Revenue Shares (%), 2026
Figure 3.17 Drivers and Restraints of the 3D Printed Dental Product Submarket, 2016
Figure 3.18 Drivers and Restraints on the 3D Printed Medical Implants Submarket, 2016
Figure 3.19 Drivers and Restraints for 3D Printed Surgical Guides and Medical Modelling Market, 2016
Figure 3.20 Drivers and Restraints for the 3D Printed Pharmaceutical Market, 2016
Figure 4.1 Leading National Markets and Market Shares for 3D Printing Technology and Products for Healthcare, 2016
Figure 4.2 Leading National Markets and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2020
Figure 4.3 Leading National Markets and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2026
Figure 4.4 The US: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.5 The US: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.6 The EU5 3D Printing Market for Healthcare: Market Share by Country (%), 2016
Figure 4.7 Revenue Forecasts ($m) for EU5 3D Printing for Healthcare National Markets, 2016-2026
Figure 4.8 Germany: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.9 Germany: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.10 France: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.11 France: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.12 The UK: 3D Printing Market for Healthcare: Revenue Forecast ($m), 2016-2026
Figure 4.13 The UK: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.14 Italy: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.15 Italy: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.16 Spain: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.17 Spain: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.18 Japan: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.19 Japan: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.20 China: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.21 China: 3D Printing Market for Healthcare: AGR Forecast (%), 2016-2026
Figure 4.22 Russia: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.23 Russia: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.24 Brazil: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.25 Brazil: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.26 India: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.27 India: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.28 RoW: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.29 RoW: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 5.1 Renishaw Healthcare Revenue ($m) 2011-2016.
Figure 5.2 Breakdown of Arcam AB's Sales by Application, 2014
Figure 5.3 Arcam AB Actual Net Sales and Net Sales of Implants (2010-2014) and Forecasted Net Sales and Net Sales of Implants (2015-16)
Figure 6.1 Recipients and Deaths from Those on the Kidney Transplant Waiting List in The US, 2014
Figure 7.1 STEP Analysis of the 3D Printing for Healthcare Industry, 2016-2026
Figure 9.1 3D Printing for the Healthcare Industry: Revenue Forecast ($m) Broken Down Into Technology and Products, 2016-2026
Figure 9.2 Printed Products for the Healthcare Industry by Submarket: Comparisons of Revenue ($m), 2015, 2020 and 2026
Figure 9.3 Leading National Markets in the 3D Printing Industry for Healthcare: Market Shares in 2016, 2020, 2026

Companies Listed
3D Bioprinting Solutions
3D Synthesis
3D Systems
3T RPD
4WEB Medical
5N Plus
Air Force Research Laboratory
Adler Ortho
Alphaform AG
America Makes
American Cancer Society
Anatomics
Andiamo
ANSYS
Aortica
APandC
Aprecia Pharmaceuticals
Arcam AB
Armed Forces Institute for Regenerative Medicine
Artivasc 3D
Asian Manufacturing Association
Autodesk
Autodesk Within
B3KD
Beijing AKEC
BestinClass SA
Bio 3D Technologies
Biomet
Bionics Institute
Blohm Jung
Boeing Company
Bonassar Research Group
CandA Tool
CalRAM
Canon
Chinese Food and Drug Administration
Chinese Ministry of Science and Technology
Clemson University
Commonwealth Scientific and Industrial Research Organisation
Compass3D
Cornell University
CPA Group
CTI Renato Archer
Dante Pazzanese Cardiology Institute
Deakin University
Deloitte Consulting
Dentca
DePuy Synthes
Deutsches Herzzentrum Berlin
DiSanto Technology
Drexel University
Emerging Implant Technologies
EnvisionTEC
EOS
Epson
Erasmus Medical Center
ETH Zurich
European Commission
European Medicines Agency
Eyedrivomatic
FDA Centre for Devices and Radiological Health
Federal Aviation Administration
FirstSurface
Focus Economics
Food and Drug Administration
Food and Drug Administration Centre for Devices and Radiological Health
Formlabs
Fraunhofer Institutes
Fripp Design and Research
Fundamentals of Robotic Gynecologic Surgery
Geomagic
GrabCAD
Great Ormond Street Hospital for Children
Grid Logic Incorporated
Harvard University
Harvest Technologies
Hewlett-Packard
Howard Hughes Medical Institute
iBox Printers
Imaginarium
Indiegogo
Industry Alliance of China 3D Printing Technology
Innovate UK
Interfacial Solutions
Intuitive Surgical
Invetech
Italian Digital Biomanufacturing Network
Janssen Research and Development
Johnson and Johnson
Joimax
Journal of Biomedical Materials Research
Kyoto University Graduate School of Medicine
Knight Cancer Institute of Oregon Health and Science University
Lab 22
Laser Zentrum Hannover
LayerWise
Lima Corporate
Lincsolution
Leapfrog
Leiden University
Lockheed Martin
L'Oreal
Maastricht Instruments B.V.
MakerBot
Manchester Metropolitan University
Massachusetts Institute of Technology
Materialise NV
Mattel Children's Hospital
Mayo Clinic
MCP HEK Tooling
Medical Modeling Inc.
Medicines and Healthcare Regulatory Agency
Merck and Co.
Michael J Fox Foundation
Michigan Technological University
Ministry of Industry and Information Technology
MirrorMe3D
Mobelife
MobileODT
MTU Aero Engines
Nakashima Medical
Nano 3D Biosciences
Nanyang Technological University
NASA
National Engineering Research Centre of Rapid Manufacturing
National Institute of Health
National Institute of Health 3D Print Exchange
National Kidney Foundation
National Additive Manufacturing Innovation Institute
Next 21
NHS
North Carolina State University
Northrop Grumman
NYU Langone Medical Center
OBL
Optomec
Organovo
Organisation for Economic Co-operation and Development (OECD)
Osteopore International
Oxford Performance Materials
Paramount Industries
Peking University 3rd Hospital
Pfizer
Proto Labs
Protosys Technologies
Queen's Medical Centre
Rainbow BioSciences
Rainbow Coral Corp.
RedEye
RegenHU
Renishaw
Replica 3dm
REVOLUTION Medicines
Revotek
Rice University
Roche
Rokit
Royal Perth Hospital
Salamanca University Hospital
Salisbury District Hospital
Siemens Corporation
Simbionix
Singapore Centre for 3D Printing
SIU System
Sixense
Smith and Nephew
Solid Concepts
South Korean Ministry of Trade, Industry and Energy
South Korean Ministry of Science, ICT and Future Planning
Southampton General Hospital
State Food and Drug Administration
Stratasys
Stryker
Technology Strategy Board
Teijin Nakashima Medical
TeVido Biodevices
Texas AandM University
Texas Tech University
The Cronin Group
TinkerCAD
Tissue Regeneration Systems
Toshiba
Tronrud
Tsingua University
TU Berlin
UCL School of Pharmacy
Ultimaker
UniQuest
United Therapeutics
University College London
University of California
University of Central Lancashire
University of Glasgow
University of Groningen
University of Iowa
University of Michigan
University of North Carolina
University of Northern Iowa
University of Nottingham
University of Pennsylvania
University of Queensland
University of Saskatchewan
University of Sheffield
University of Wisconsin
University of Texas at El Paso
U.S. Army
U.S. Department of Health and Human Services
Venture Investors
Vidar Systems Corp.
VIVOS Dental
Wake Forest Institute for Regenerative Medicine (WFIRM)
Walter Reed National Military Medical Centre
Weill Cornell Medical College
Wellcome Trust
Wohlers Associates
World Health Organization (WHO)
World Intellectual Property Organisation
Wyss Institute at Harvard University
Xilloc Medical
Zdravprint
Zimmer Biomet

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
3D Printing Ceramics Market by Type, Form, End User - Global Forecast to 2021

3D Printing Ceramics Market by Type, Form, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

“End-user segment is one of the driving factors, as 3D printing ceramics are widely used in high-thermal applications” The global 3D printing ceramics market is expected to grow at a CAGR of 29.6% ...

Rapid Prototyping Materials Market by Type, Form, Function, End User - Global Forecast to 2021

Rapid Prototyping Materials Market by Type, Form, Function, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

“The rapid prototyping materials market is projected to grow at a CAGR of 26.8% from 2016 to 2021” The rapid prototyping materials market is expected to reach USD 903.8 million by 2021, at a CAGR of ...

3D Printing Software Markets 2016: A Ten Year Forecast And Opportunity Analysis

3D Printing Software Markets 2016: A Ten Year Forecast And Opportunity Analysis

  • $ 4995
  • Industry report
  • October 2016
  • by SmarTech

The 3D printing industry has been riding a historic growth wave since 2012, but today in 2016 the landscape for opportunities is continuing to evolve. With significantly increased competitiveness causing ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.